ResearcherUniversity Hospital FrankfurtNo recent work listed
Wolfgang Glienke
Matched on OpenAlex author ID A5010755799. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 1
2011: 2 papers · 2012: 1 paper
Papers 3
- The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines. Co-author DOI 10.1007/s13277-011-0290-2↗
- Downregulation of STAT3 signaling induces apoptosis but also promotes anti-apoptotic gene expression in human pancreatic cancer cell lines. Co-author DOI 10.1007/s13277-010-0143-4↗
- Targeting STAT3 signaling in pancreatic cancer promotes antiapoptotic gene expression. Co-author DOI 10.1097/mpa.0b013e318204ea7b↗
Closest collaborators
The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Lothar Bergmann · 3 shared papers, 2011–2012 · strength 0.13
- Paper The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancr… DOI 10.1007/s13277-011-0290-2↗
- Paper Downregulation of STAT3 signaling induces apoptosis but also promotes anti-apoptotic gene expression in human pancreati… DOI 10.1007/s13277-010-0143-4↗
- Paper Targeting STAT3 signaling in pancreatic cancer promotes antiapoptotic gene expression. DOI 10.1097/mpa.0b013e318204ea7b↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.